Frontlight ResearchEarly access
Trial site
Kyoto Kuramaguchi Medical Center
- 1running trial
- 3closed trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma3 trials
- Amyloidosis1 trial
- Phase
- Phase 33 trials
- Phase 1/21 trial
- Status
- Completed3 trials
- Active, not recruiting1 trial
- Lead sponsor
- Janssen Research & Development, LLC3 trials
- Janssen Pharmaceutical K.K.1 trial
Running trials
Closed trials
Completed
A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026